Tasken lab was established in 1997 at University of Oslo. Now located at Dept. of Cancer Immunology, Institute of Cancer Research, Norwegian Radium Hospital.
The next Acta Oncologica Nordic Precision Cancer Medicine Symposium will take place in Oslo 15-17 September 2025 - save the date!
A special NPCM symposium collection originating from the NPCM2023 conference has now been published. For more information: https://t.co/pL0w51fnVC
Check out our editorial on the European intitiatives @PCM4EU and @PRIMEROSE_EU to combine expertise across borders to implement equitable and sustainable precision cancer medicine, published in HealthcareTech Outlook end of 2023: https://t.co/innSUy4FHW
#NobelPrize and how tightly coupled R&D and application must be - @JOlweus@jarottingen and I discuss in @Aftenposten the fantastic story of covid and cancer vaccine development as shown by Özlem Türeci @BioNTech in talks @DNVA1 and @Oslounivsykehus
https://t.co/L0Zfm1bLoC
📑Check out our latest publication in @EurJImmunol where @garciadiaznuria@QianWei_ous and @KjetilTasken review the pipeline of small molecule inhibitors that have shown to affect regulatory T cells and may have applications in the treatment of cancer.
https://t.co/KArrtypZun
We seek a new Unit Leader for our Preclinical Proton Therapy and Imaging Unit at the Institute for Cancer Research, Oslo University Hospital. In connection with establishing a new proton therapy center at our Hospital. Deadline 1st December
https://t.co/zbhiXdb0Sg
Many congratulations to our group leader @KjetilTasken for being awarded with the Acta Oncologica Award 2024 by the Swedish Society of Oncology! 🥳
Very well-deserved recognition of his scientific and strategic work in the oncology field.
More info here 👇🏻
Recommend to read this trail of 9 tweets by @DNVA1 - about the mRNA vaccine technology, cancer and covid vaccines, the work by Profs Özlem Türeci and Ügur Sachin in BioNTech and the link to the 2023 Nobel Prize! NB Academy talk next week by Özlem Türeci.
Great news!
We are very happy to celebrate Youxian Li’s Young Talent grant “T-cell-mediated proinflammatory cell death and lysis in cancer” funded with 8mill NOK by @forskningsradet 🥳
Congratulations!
We have the ICR #Scienceday today at @Oslounivsykehus. >265 people and >120 posters. We are going to spend the whole discussing our own Science 😊. Just starting.
Gratulerer så mye med UiOs innovasjonspris 2023 @KjetilTasken - meget velfortjent! Les mer om overrekkelsen i universitetsaulaen: https://t.co/qQg5O2qmio
Great talks on the development and use of the CRISPR/Cas9 Technology by @NobelPrize Laureate @e__charpentier and @sigridbratlie! True curiosity-driven research in microbiology leading to revolutionary applications in medicine and agriculture. #BonnevieLectures. @UniOslo
Congratulations @yin_yanping and @SigridSkanland for receiving the @Oslounivsykehus mention for the best original research article about functional testing to stratify PI3K inhibitor responses on #CLL patients. Very well deserved!
https://t.co/a0VW9UUIpU